SI-BONE, Inc. Financials
Quarterly XBRL submissions from SEC 10-K and 10-Q filings.
Income Statement (Last 8 Quarters)
(3)| Period | Revenue | YoY % | Net Income | YoY % | Operating Income | EPS |
|---|---|---|---|---|---|---|
| Q3 FY202510-Q · 2025-09-30 | $48.7M | — | -$4.6M | — | -$5.4M | -$0.11 |
| Q2 FY202510-Q · 2025-06-30 | $2.2M | — | -$6.2M | — | -$7.0M | -$0.14 |
| Q1 FY202510-Q · 2025-03-31 | $44.8M | — | -$6.5M | — | -$7.5M | -$0.15 |
Balance Sheet
| Period | Total Assets | Total Liabilities | Cash & Equivalents | Shareholders Equity |
|---|---|---|---|---|
| Q3 FY202510-Q | $234.3M | $62.1M | $26.5M | $172.1M |
| Q2 FY202510-Q | $230.9M | $60.6M | $34.1M | -$444.0M |
| Q1 FY202510-Q | $227.3M | $60.0M | $41.2M | $320.0K |
Cash Flow Highlights
| Period | Operating Income | Net Income | Gross Profit | Shares Outstanding |
|---|---|---|---|---|
| Q3 FY202510-Q | -$5.4M | -$4.6M | $38.8M | 43,273,382 |
| Q2 FY202510-Q | -$7.0M | -$6.2M | $38.8M | 43,014,093 |
| Q1 FY202510-Q | -$7.5M | -$6.5M | $37.7M | 42,479,600 |
Filings
(4)Methodology
Every figure on this page is pulled directly from SI-BONE, Inc.'s own XBRL submissions to the U.S. Securities and Exchange Commission. XBRL is the standardized tagging format the SEC requires for line items in 10-K and 10-Q filings, which means revenue, net income, and balance-sheet entries are reported by the company itself — not estimated by us.
Cayman Journal reconciles preferred GAAP tags (for example, Revenues, RevenueFromContractWithCustomerExcludingAssessedTax) and normalizes them so quarter-over-quarter comparability is preserved. Our automated ingestion runs nightly; markets editors spot-check flagged anomalies before they appear on the public hub. Where a tag is missing for a given period, we surface an em dash rather than impute a value.
Source documents are linked under Filings above and point to the original EDGAR submission index. Errors should be reported to [email protected].